secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zivo Bioscience, Inc. (ZIVO)
CIK:        0001101026
Form:       8-K
Filed at:   2023-11-27T23:59:59+00:00
Accession:  0001654954-23-014775
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

ZIVO Bioscience receives Nasdaq delisting notice; shares to trade on OTC Pink Sheets
--------------------------------------------------------------------------------

- Nasdaq notified ZIVO on Nov 22, 2023 of delisting for noncompliance with Listing Rule 5550(b)(1).
- Trading suspended on Nasdaq effective Nov 27, 2023; company expects to trade on OTC Pink Sheets same day under symbol ZIVO.
- Company has applied for OTCQB quotation; pending approval, shares will trade on OTC Pink Sheets.
- Transition to OTC Markets will not affect business or operations; company will continue SEC reporting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1101026/000165495423014775/0001654954-23-014775-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1101026/000165495423014775/zivo_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-014775

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer